https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
The Latin America Veterinary Laboratory Testing Service market will be USD 467.56 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031. The market is foreseen to reach USD 1003.3 million by 2031 owing to the increased veterinary hospital industry.
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 145.54(USD Billion) |
MARKET SIZE 2024 | 149.83(USD Billion) |
MARKET SIZE 2032 | 189.05(USD Billion) |
SEGMENTS COVERED | Service Type ,End-User ,Technology ,Reimbursement Model ,Accreditation ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Growing demand for personalized medicine Increasing prevalence of chronic diseases Technological advancements in laboratory testing Consolidation within the industry Focus on costeffectiveness |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Thermo Fisher Scientific ,Danaher ,Mayo Clinic Laboratories ,Meridian Bioscience, Inc. ,F. HoffmannLa Roche ,Grifols ,Laboratory Corporation of America Holdings ,Siemens Healthineers ,Invitae Corporation ,BioRad Laboratories ,Quest Diagnostics ,Abbott ,Eurofins Scientific ,DiaSorin ,Idexx Laboratories |
MARKET FORECAST PERIOD | 2024 - 2032 |
KEY MARKET OPPORTUNITIES | Precision Medicine Growing demand for personalized medicine and targeted therapies AI and Automation Advancements in AI and automation for faster and more accurate results Remote Monitoring Expansion of remote patient monitoring and telemedicine services Emerging Diagnostics Development of new and innovative diagnostic tests for complex diseases Global Expansion Increasing demand for central lab services in developing regions |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 2.95% (2024 - 2032) |
https://www.futuremarketinsights.com/privacy-policyhttps://www.futuremarketinsights.com/privacy-policy
According to Future Market Insights research, during the projected period, the Global point-of-care diagnostics market is expected to grow at a CAGR of 6.8%. The market value is projected to increase from US$ 38.7 Billion in 2023 to US$ 74.8 Billion by 2033. The point-of-care diagnostics market was valued at US$ 36.6 Billion at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 5.8% in 2023.
Data Points | Market Insights |
---|---|
Market Value 2022 | US$ 36.6 Billion |
Market Value 2023 | US$ 38.7 Billion |
Market Value 2033 | US$ 74.8 Billion |
CAGR 2023 to 2033 | 6.8% |
Share of Top 5 Countries | 56.5% |
Key Players | The key players in the Global Point-of-Care Diagnostics Market Are F. Hoffmann-La Roche Ltd, Becton Dickinson & Company, Cepheid (Danaher),Siemens Healthineers, Abbott, Diasorin S.p.a., Thermo Fisher Scientific Inc. , Qiagen, BIOMÉRIEUX, Hologic Inc., Bio Rad Laboratories, Quidel Corporation, EKF Diagnostics, SEKISUI Diagnostics, DiaSys-Diagnostic Systems GmbH, InBios International, Inc., Jiangsu Mole Bioscience Co., Ltd., ACON Laboratories, Inc., Visby Medical, Inc., UNIMA, INC. |
Scope of the Global Point-of-Care Diagnostics Industry Report
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2012 to 2022 |
Market Analysis | USD Million for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA) |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Türkiye, South Africa, and GCC Countries |
Key Segments Covered | Test Type, Sample, Product, End User, Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
In-Vitro Diagnostics Instruments Market Size 2025-2029
The in-vitro diagnostics instruments market size is forecast to increase by USD 60.9 billion at a CAGR of 9.8% between 2024 and 2029.
The market is experiencing significant growth, driven primarily by the increasing geriatric population and the potential opportunities for physician office laboratories (POLs). The aging demographic is leading to a higher demand for diagnostic tests due to the prevalence of chronic diseases among older individuals. Furthermore, POLs are gaining prominence as they offer convenience, reduced wait times, and lower costs compared to central laboratories. However, market growth is not without challenges. Strained laboratory budgets and lowering reimbursements are affecting instrument sales, necessitating cost-effective solutions and innovative business models. Regulatory hurdles also impact adoption, as stringent regulations require extensive validation and approval processes for new instruments. Techniques like liquid biopsy and molecular diagnostics are gaining traction in oncology and infectious diseases.
Supply chain inconsistencies, particularly in raw materials and components, temper growth potential and require robust risk management strategies. Companies seeking to capitalize on market opportunities and navigate challenges effectively must focus on cost reduction, regulatory compliance, and supply chain resilience. By addressing these challenges and leveraging the growing demand for diagnostic instruments, market participants can seize opportunities and maintain a competitive edge. Personalized medicines and emerging markets, such as China and India, are driving demand for advanced diagnostic technologies, including companion diagnostics (CDx) and liquid biopsy.
What will be the Size of the In-Vitro Diagnostics Instruments Market during the forecast period?
Request Free Sample
The market in the US is witnessing significant growth due to the integration of advanced technologies such as predictive diagnostics, machine learning, and molecular techniques. In disease screening, in-situ hybridization and image analysis are key techniques used, while viral load testing and biopsy analysis enable early detection and personalized treatment plans. Machine learning algorithms enhance data interpretation and clinical decision support, enabling more accurate results. Microbiology analyzers leverage next-generation sequencing platforms and mass spectrometry for infectious disease testing, while automated sample handling and error management systems ensure precision and efficiency. Decentralized testing and real-time PCR enable quick results, reducing the need for centralized laboratories. While routine diagnostic testing maintains a higher volume of activity, the growth of specialty testing in esoteric, pathology, and genetic testing areas is projected to outpace the overall market.
Automated immunoassay systems and digital PCR are revolutionizing serological testing, providing quantitative results. Lab automation, including automated microscopy and specimen management, streamlines workflows and reduces errors. Pathology informatics and laboratory informatics enable data interpretation and sample tracking, improving overall efficiency and patient monitoring. Multiplex assays and microarray technology offer increased throughput and reduced costs, making diagnostics more accessible to healthcare providers and patients. Cloud computing and clinical decision support systems enable remote access to diagnostic data, enhancing collaboration and improving patient care. Tissue diagnostics and lateral flow assays offer non-invasive testing options, expanding the scope of in-vitro diagnostics. Overall, the US market is poised for growth, driven by these trends and advancements in technology.
How is this In-Vitro Diagnostics Instruments Industry segmented?
The in-vitro diagnostics instruments industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
Product
Immunochemistry
Clinical microbiology
Molecular diagnostics
Others
End-user
Hospitals and diagnostic laboratories
Academic and research institutes
Home care
Application
Infectious diseases
Oncology
Diabetes
Cardiology
Others
Geography
North America
US
Canada
Mexico
Europe
France
Germany
UK
APAC
China
India
Japan
South America
Brazil
Rest of World (ROW)
By Product Insights
The immunochemistry segment is estimated to witness significant growth during the forecast period. The market in the US and Europe is witnessing significant trends, driven by the integration of advanced technologies and the increasing demand for qui
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Veterinary Diagnostics is segmented by Application (Livestock, Pets, Diagnostics Labs, Research) , Type (Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 96.25(USD Billion) |
MARKET SIZE 2024 | 98.86(USD Billion) |
MARKET SIZE 2032 | 122.54(USD Billion) |
SEGMENTS COVERED | Product Type ,Test Type ,End User ,Technology ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Increasing demand for personalized medicine Growing prevalence of chronic diseases Technological advancements in laboratory automation Consolidation and partnerships among major players Government initiatives to improve healthcare infrastructure |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Laboratory Corporation of America Holdings ,Abbott Laboratories ,Hologic ,Illumina ,QIAGEN ,Siemens Healthineers ,Thermo Fisher Scientific ,Ortho Clinical Diagnostics ,F. HoffmannLa Roche ,Johnson & Johnson ,Merck KGaA ,Sysmex Corporation ,Danaher Corporation ,BioRad Laboratories |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Growing demand for personalized medicine Advancements in diagnostic technologies Rising prevalence of chronic diseases Increasing healthcare expenditure Expanding population of elderly patients |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 2.72% (2025 - 2032) |
https://www.futuremarketinsights.com/privacy-policyhttps://www.futuremarketinsights.com/privacy-policy
The global anatomic pathology market size reached a valuation of US$ 32.5 Million in 2022 and is likely to grow at a robust CAGR of 8.2% between 2022 and 2030, surpassing US$ 61.1 Million by the end of 2030. Growth in the global anatomic pathology market is driven by rising application of anatomic pathology in disease diagnosis and drug discovery and development.
Attribute | Details |
---|---|
Anatomic Pathology Market Size (2022) | US$ 32.5 million |
Anatomic Pathology Market Revenue Forecast (2030) | US$ 61.1 million |
Anatomic Pathology Market Growth Rate (2022 to 2030) | 8.2% CAGR |
North America Market Share | 37.1% |
How The Market Progressed Till June 2022?
Particulars | Details |
---|---|
H1, 2021 | 8.21% |
H1, 2022 Projected | 8.20% |
H1, 2022 Outlook | 7.80% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 40 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (-) 41 ↓ |
Scope of Report
Attribute | Details |
---|---|
Forecast Period | 2022 to 2030 |
Historic Data Available for | 2015 to 2021 |
Market Analysis | USD Million for Value |
Report Coverage | Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
Key Segments Covered |
|
Key regions covered | North America
|
End User |
|
Key companies profiled | Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., F.Hoffmann-La Roche AG, Cardinal Health, Inc.,BioGenex, NeoGenomics, Bio SB, Agilent Technologies |
Customization & pricing | Available upon request |
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Medical laboratory technology is segmented by Application (Hospitals, Diagnostic Laboratories, Research Institutions, Academic Institutions, Public Health Agencies), Type (Clinical Chemistry, Hematology, Microbiology, Immunology, Molecular Diagnostics) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Lab Screening Test Kit is segmented by Application (Hospitals, Clinics, Laboratories, Medical research, Diagnostic testing), Type (Diagnostic tests, Medical tests, Laboratory supplies, Healthcare products, Medical devices) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Clinical Laboratory Tests is segmented by Application (Healthcare, Diagnostics) , Type (Diagnostic Kits, PCR Testing, Blood Panels, Pathogen Detection, Biochemical Analyzers) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 4.99(USD Billion) |
MARKET SIZE 2024 | 5.27(USD Billion) |
MARKET SIZE 2032 | 8.2(USD Billion) |
SEGMENTS COVERED | Test Type, Application, End User, Region, Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Growing prevalence of urinary disorders, Increasing demand for rapid diagnostics, Technological advancements in testing devices, Shift towards decentralized healthcare settings, Rising geriatric population and chronic diseases |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Roche, Becton Dickinson, Quidel, Eiken Chemical, Analyticon Biotechnologies, F. HoffmannLa Roche, AccuBioTech, URIT Medical Electronic, Abbott Laboratories, Danaher, Thermo Fisher Scientific, Nova Biomedical, Acon Laboratories, Sysmex, Siemens Healthineers |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Technological advancements in diagnostics, Increasing prevalence of urinary disorders, Growing demand for home healthcare, Rising aging population, Integration with digital health platforms |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.68% (2025 - 2032) |
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Diagnostic Specialty Enzymes is segmented by Application (Hospitals, Diagnostic labs, Research centers) , Type (Amylase, Lipase, Protease, Lactase, DNA polymerase) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 128.21(USD Billion) |
MARKET SIZE 2024 | 133.74(USD Billion) |
MARKET SIZE 2032 | 187.5(USD Billion) |
SEGMENTS COVERED | Service Type ,Sample Type ,Test Methodology ,End-User ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Technological advancements Increasing demand for personalized medicine Growing prevalence of chronic diseases Focus on cost efficiency Strategic partnerships |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | SGS ,BioReference Laboratories ,TUV SUD ,Charles River Laboratories ,Intertek ,Eurofins Scientific ,Sonic Healthcare ,LabCorp ,SGS HK ,Genova Diagnostics ,Quest Diagnostics ,ARUP Laboratories ,Abbott Laboratories ,ALS Limited ,Bureau Veritas |
MARKET FORECAST PERIOD | 2024 - 2032 |
KEY MARKET OPPORTUNITIES | Personalized medicine Pointofcare testing Data analytics Automation Telepathology |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.31% (2024 - 2032) |
https://www.archivemarketresearch.com/privacy-policyhttps://www.archivemarketresearch.com/privacy-policy
The laboratory plasticware market is estimated to reach $2.25 billion by 2033, expanding at a CAGR of 4.8% over the forecast period (2025-2033). Key drivers of this growth include the increasing demand for plasticware in hospitals, research institutions, diagnostic centers, and the pharmaceutical and biotechnology industries. These industries heavily rely on plasticware for sample collection, handling, storage, and analysis. Furthermore, the growing need for reliable and convenient laboratory supplies, coupled with the rising focus on infection control, is driving the adoption of disposable plasticware. The market is segmented by material type, end-use, and region. Major material types used in laboratory plasticware include Low Density Polyethylene (LDPE), High Density Polyethylene (HDPE), Polystyrene, Polyvinyl Chloride (PVC), Polymethylpentene (PMP), and others. End-use applications span hospitals, research & academic institutes, diagnostic centers, pharmaceutical & biotechnology industries, and others. Regionally, the market is divided into North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa. North America currently holds the largest market share due to the presence of well-established healthcare infrastructure and a high demand for laboratory supplies. Asia Pacific is expected to witness significant growth over the forecast period, driven by the expanding healthcare sector and increasing research activities in the region. The global laboratory plasticware market size is projected to reach USD 10.5 billion units by 2027 from USD 7.8 billion units in 2022, exhibiting a CAGR of 4.5% during the forecast period. Various factors, such as growing demand from healthcare facilities, pharmaceutical industries, and research institutes globally, are expected to drive the market over the next five years. Recent developments include: In December 2023, Eppendorf SE Hamburg established a collaboration with Neste to enhance the development of laboratory products manufactured from plastic renewable raw materials. The strategic relationship enabled the development of a new range of renewable plastic lab consumables called Eppendorf consumables BioBased. , In October 2023, Berry introduced the first 20 and 25 liter containers comprising 35% recycled material, which have received UN approval for the transport of hazardous commodities for five of the six model liquids in the UN assessment. The addition of these additional containers to the company's famous Optimum range will help businesses accomplish their sustainability goals while also meeting customer demand for more sustainable packaging alternatives. .
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global PCT Fast Test Kit is segmented by Application (Healthcare, Diagnostics, Emergency care, Laboratories, Hospitals), Type (Fast test, Diagnostic, Medical, PCT, Portable) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketintelligence.com/privacy-policyhttps://www.htfmarketintelligence.com/privacy-policy
Global Microplate Instrumentation and Supplies Market Breakdown by Application (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics, Environmental Testing, Research, Environmental Monitoring, Academic Labs) by Type (Absorbance Readers, Fluorescence Readers, Luminescence Readers, Hybrid Readers, Automated Systems) by Type of Instrumentation (Microplate Readers, Microplate Washers, Microplate Incubators, Microplate Shakers, Microplate Dispensers) by Type of Microplates (6-Well Plates, 24-Well Plates, 96-Well Plates, 384-Well Plates, 1536-Well Plates) by End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Contract Research Organizations (CROs), Environmental and Food Testing Labs) and by Geography (North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Point of Care Testing is segmented by Application (Diagnostics, Healthcare, Home Healthcare, Emergency Medicine, Critical Care), Type (Blood Glucose Meters, Pregnancy Tests, Rapid Diagnostic Tests (RDTs), Blood Gas Analyzers, Coagulation Analyzers) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Laboratory Heating Plates is segmented by Application (Research labs, pharmaceuticals, universities, testing, diagnostics) , Type (Digital heating plates, laboratory hotplates, magnetic stirring plates, variable temperature controllers, ceramic heating elements) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Porphyrin Testing is segmented by Application (Healthcare, medical diagnostics, research), Type (Medical, Diagnostic, Testing, Health, Laboratory) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Veterinary Reference Laboratory is segmented by Application (Veterinary care, animal health, diagnostics) , Type (Diagnostic testing, clinical pathology, immunology, molecular biology, microbiology) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
The Latin America Veterinary Laboratory Testing Service market will be USD 467.56 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031. The market is foreseen to reach USD 1003.3 million by 2031 owing to the increased veterinary hospital industry.